Matthew Caufield
Stock Analyst at HC Wainwright & Co.
(0)
# 4996
Out of 5,218 analysts
108
Total ratings
15.66%
Success rate
-38.23%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Phathom Pharmaceutic... | Reiterates: Buy | 28 28 | 7.87 | 255.78% | 7 | Dec 12, 2024 | |
Opus Genetics | Reiterates: Buy | 8 8 | n/a | n/a | 1 | Dec 12, 2024 | |
Immunic | Initiates Coverage On: Buy | 10 | 1.13 | 784.96% | 1 | Nov 25, 2024 | |
Adverum Biotechnolog... | Reiterates: Buy | 30 30 | 5.38 | 457.62% | 4 | Nov 19, 2024 | |
Eyenovia | Downgrades: Neutral | 12 2 | 0.08 | 2400% | 14 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 3 3 | 8.48 | -64.62% | 3 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 7 7 | 5.43 | 28.91% | 3 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 36 36 | 6.49 | 454.7% | 15 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 12 | 2.19 | 447.95% | 2 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 5 | 0.47 | 963.83% | 5 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 30 30 | 11.83 | 153.59% | 4 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 38 38 | 31 | 22.58% | 3 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14 12 | 3.25 | 269.23% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 2 2 | 0.18 | 1011.11% | 6 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 20 18 | n/a | n/a | 9 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 2 2 | 1.97 | 1.52% | 5 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 4.94 | 102.43% | 10 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 | 1.12 | 792.86% | 4 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 28 | 248.1 | -88.71% | 1 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 35 40 | n/a | n/a | 6 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | n/a | n/a | 1 | Jul 18, 2022 |